135 related articles for article (PubMed ID: 36723086)
1. Rapid screening of pharmaceutical products for elemental impurities by a high-resolution portable energy dispersive X-ray fluorescence spectrometer using an efficient fundamental parameter method.
Zhu L; Teng Y; Han W; Yin L; Teng X
Analyst; 2023 Feb; 148(5):1116-1122. PubMed ID: 36723086
[TBL] [Abstract][Full Text] [Related]
2. Application of X-ray fluorescence spectrometry for screening pharmaceutical products for Elemental Impurities according to ICH guideline Q3D.
Sauer B; Xiao Y; Zoontjes M; Kroll C
J Pharm Biomed Anal; 2020 Feb; 179():113005. PubMed ID: 31812806
[TBL] [Abstract][Full Text] [Related]
3. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D.
Pluháček T; Ručka M; Maier V
Anal Chim Acta; 2019 Oct; 1078():1-7. PubMed ID: 31358206
[TBL] [Abstract][Full Text] [Related]
4. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.
Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S
J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of wavelength dispersive X-ray fluorescence spectrometry for the determination of metal impurities in pharmaceutical products and dietary supplements in view of regulatory guidelines.
Figueiredo A; Fernandes T; Costa IM; Gonçalves L; Brito J
J Pharm Biomed Anal; 2016 Apr; 122():52-8. PubMed ID: 26845202
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉.
Chahrour O; Malone J; Collins M; Salmon V; Greenan C; Bombardier A; Ma Z; Dunwoody N
J Pharm Biomed Anal; 2017 Oct; 145():84-90. PubMed ID: 28654780
[TBL] [Abstract][Full Text] [Related]
7. Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry.
Breckenridge L; Oni Y; Evans C; Franck J; Wood S; Xu M; Sahin E; Zacour B
PDA J Pharm Sci Technol; 2023; 77(3):197-210. PubMed ID: 36241213
[TBL] [Abstract][Full Text] [Related]
8. Determination of arsenic, cadmium, mercury, lead and nickel as elemental impurities in atorvastatin calcium by inductively coupled mass spectrometer.
Pal AK; Sundararajan R
Eur J Mass Spectrom (Chichester); 2022 Feb; 28(1-2):3-11. PubMed ID: 35656753
[TBL] [Abstract][Full Text] [Related]
9. Study of the compatibility of oral magnesium oxide preparations sold in Japan with the ICH-Q3D guideline for elemental impurities.
Satoh M; Motokawa K; Uesawa Y; Ishikawa Y; Maeda H; Iida K; Tanaka H; Kosugi T; Nishizawa K
Drug Discov Ther; 2021 Nov; 15(5):227-235. PubMed ID: 34719603
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Extractable Elements from Elastomers.
Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D
PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347
[TBL] [Abstract][Full Text] [Related]
11. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake - comparative analysis by ICP-OES and ICP-MS.
Janchevska K; Stafilov T; Memed-Sejfulah S; Bogdanoska M; Ugarkovic S; Petrushevski G
Drug Dev Ind Pharm; 2020 Mar; 46(3):456-461. PubMed ID: 31999195
[TBL] [Abstract][Full Text] [Related]
12. Method for determination of elemental impurities in metronidazole benzoate using inductively coupled plasma mass spectrometry.
Tian M; Zhang H; Fan H; Yin M; Wang W; Shi C
Eur J Mass Spectrom (Chichester); 2024 Feb; 30(1):60-64. PubMed ID: 37926973
[TBL] [Abstract][Full Text] [Related]
13. A Risk-Based Approach to Evaluate and Control Elemental Impurities in Therapeutic Proteins.
Luo Y; Sekhar C; Lee H; Fujimori K; Ronk M; Semin D; Nashed-Samuel Y
J Pharm Sci; 2020 Nov; 109(11):3378-3385. PubMed ID: 32745562
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an ICP-OES method for quantitation of elemental impurities in tablets according to coming US pharmacopeia chapters.
Støving C; Jensen H; Gammelgaard B; Stürup S
J Pharm Biomed Anal; 2013 Oct; 84():209-14. PubMed ID: 23850936
[TBL] [Abstract][Full Text] [Related]
15. Quantitative X-ray fluorescence analysis: Trace level detection of toxic elemental impurities in drug product by ED-XRF spectrometer.
Chowdhury AR; Maheshwari N; Soni J; Kapil M; Mehta T; Mukharya A
J Pharm Biomed Anal; 2020 Sep; 189():113292. PubMed ID: 32645616
[TBL] [Abstract][Full Text] [Related]
16. Elemental Impurities in Pharmaceutical Excipients.
Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
[TBL] [Abstract][Full Text] [Related]
17. Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirements.
Muller AL; Oliveira JS; Mello PA; Muller EI; Flores EM
Talanta; 2015 May; 136():161-9. PubMed ID: 25702998
[TBL] [Abstract][Full Text] [Related]
18. Safety Assessment of the Trace Element Impurities Ni and Cr in Pharmaceutical Herbal Products for Teething from Polish Pharmacies.
Jurowski K; Krośniak M; Fołta M; Tatar B; Cole M; Piekoszewski W
Biol Trace Elem Res; 2019 Oct; 191(2):517-521. PubMed ID: 30684140
[TBL] [Abstract][Full Text] [Related]
19. Determination of trace elements in ibuprofen drug products using microwave-assisted acid digestion and inductively coupled plasma-mass spectrometry.
Holmfred E; Alrijjal A; Chamberlain CP; Maher K; Stürup S
Heliyon; 2024 Jan; 10(1):e23566. PubMed ID: 38205305
[TBL] [Abstract][Full Text] [Related]
20. How One Might Experimentally Determine if Container Closure Systems and Their Components and Materials of Construction Contribute Elemental Impurities To Packaged Pharmaceutical Drug Products.
Jenke D
PDA J Pharm Sci Technol; 2019; 73(2):181-190. PubMed ID: 30232139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
